These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 16760512)
21. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis. Everlien H; Hockertz S Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050 [TBL] [Abstract][Full Text] [Related]
22. Slc11a1-mediated resistance to Salmonella enterica serovar Typhimurium and Leishmania donovani infections does not require functional inducible nitric oxide synthase or phagocyte oxidase activity. White JK; Mastroeni P; Popoff JF; Evans CA; Blackwell JM J Leukoc Biol; 2005 Mar; 77(3):311-20. PubMed ID: 15601666 [TBL] [Abstract][Full Text] [Related]
23. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. Murray HW; Nathan CF J Exp Med; 1999 Feb; 189(4):741-6. PubMed ID: 9989990 [TBL] [Abstract][Full Text] [Related]
24. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884 [TBL] [Abstract][Full Text] [Related]
25. Studies on stibanate resistant Leishmania donovani isolates of Indian origin. Pal S; Mandal A; Duttagupta S Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284 [TBL] [Abstract][Full Text] [Related]
26. Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis. Bhattacharjee A; Majumder S; Majumdar SB; Choudhuri SK; Roy S; Majumdar S Int J Antimicrob Agents; 2015 Mar; 45(3):268-77. PubMed ID: 25600891 [TBL] [Abstract][Full Text] [Related]
28. Leishmania donovani: pilot study for evaluation of therapeutic effects of inosine analogs against amastigotes in vitro and in vivo. Morishige K; Aji T; Ishii A; Yasuda T; Wataya Y Exp Parasitol; 1995 Jun; 80(4):665-71. PubMed ID: 7758547 [TBL] [Abstract][Full Text] [Related]
30. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10. Bhaumik SK; Naskar K; De T Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771 [TBL] [Abstract][Full Text] [Related]
31. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis. Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627 [TBL] [Abstract][Full Text] [Related]
32. Lymphokine mediated microbicidal activity of peritoneal macrophages from Leishmania donovani infected and drug treated BALB/c mice. Sodhi S; Ganguly NK; Malla N; Mahajan RC Jpn J Exp Med; 1989 Jun; 59(3):103-8. PubMed ID: 2554031 [TBL] [Abstract][Full Text] [Related]
33. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani. Sinha R; Roychoudhury J; Palit P; Ali N Antimicrob Agents Chemother; 2015 Jan; 59(1):344-55. PubMed ID: 25367907 [TBL] [Abstract][Full Text] [Related]
34. Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms. Murray HW; Delph-Etienne S J Infect Dis; 2000 Feb; 181(2):795-9. PubMed ID: 10669380 [TBL] [Abstract][Full Text] [Related]
35. The role of mannose receptor during experimental leishmaniasis. Akilov OE; Kasuboski RE; Carter CR; McDowell MA J Leukoc Biol; 2007 May; 81(5):1188-96. PubMed ID: 17261547 [TBL] [Abstract][Full Text] [Related]
36. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology. Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399 [TBL] [Abstract][Full Text] [Related]
37. Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India. Singh SK; Bimal S; Narayan S; Jee C; Bimal D; Das P; Bimal R Exp Parasitol; 2011 Feb; 127(2):552-8. PubMed ID: 21070771 [TBL] [Abstract][Full Text] [Related]
38. Immune responses of Leishmania donovani infected BALB/c mice following treatment with free and vesicular sodium stibogluconate formulations. Banduwardene R; Mullen AB; Carter KC Int J Immunopharmacol; 1997 Apr; 19(4):195-203. PubMed ID: 9373770 [TBL] [Abstract][Full Text] [Related]
39. Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice. Roychoudhury J; Sinha R; Ali N PLoS One; 2011 Mar; 6(3):e17376. PubMed ID: 21423750 [TBL] [Abstract][Full Text] [Related]
40. Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver. Murray HW; Zhang Y; Zhang Y; Raman VS; Reed SG; Ma X Infect Immun; 2013 Jul; 81(7):2318-26. PubMed ID: 23589575 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]